When replacing a defective aortic valve with a new one, restoring function is the first priority. However, variables such as durability, length of surgery, duration of heart stoppage, size of the surgical incision, postoperative pain, and complications are other important considerations. In a presentation at the 96th AATS Annual Meeting, the results of the TRANSFORM Trial, a large multicenter study evaluating the safety and performance of an investigational rapid deployment aortic valve replacement (RDAVR) system for patients with severe aortic stenosis, was presented. The results show that compared to more conventional methods, this system was associated with excellent one-year survival, reduced the duration of heart stoppage, and was associated with clinically acceptable postoperative complication rates.
↧